Russia’s fast-track coronavirus vaccine draws outrage over safety

  title={Russia’s fast-track coronavirus vaccine draws outrage over safety},
  author={E. Callaway},
  pages={334 - 335}
The immunization is the first approved for widespread use but could be dangerous because it hasn’t been tested in large trials, say researchers. The immunization is the first approved for widespread use but could be dangerous because it hasn’t been tested in large trials, say researchers. Russian President Vladimir Putin receives a video report about registration of the tested and registered coronavirus vaccine 
Efforts towards a COVID-19 vaccine.
  • H. Brüssow
  • Medicine, Biology
  • Environmental microbiology
  • 2020
An overview of vaccine candidates in development, including preclinical and clinical testing, and it also mentions some of the societal problems of vaccine acceptance. Expand
Platforms Exploited for SARS-CoV-2 Vaccine Development
This review describes the latest advances in the development of SARS-CoV-2 vaccines for humans, mainly focusing on the lead candidates in clinical trials, and seeks to provide both the advantages and the disadvantages of the leading platforms used in current vaccine development, based on past vaccine delivery efforts for non-SARS CoV- 2 infections. Expand
The Current Status of COVID-19 Vaccines
Evaluation of immune responses in a small number of individuals has demonstrated similar or superior levels of neutralizing antibodies in comparison to immunogenicity detected in COVID-19 patients. Expand
An Appraisal of the Current Scenario in Vaccine Research for COVID-19
This review is aimed at providing the current scenario and future perspectives in the development of vaccines against SARS-CoV-2, and identifying its genomic sequence and the presenting antigen. Expand
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
This review will focus on the eight vaccine candidates that entered Phase 1 clinical trials in mid-May, including AstraZeneca/Oxford's AZD1222, Moderna's mRNA-1273 and Sinovac's CoronaVac vaccines, which are currently in advanced stages of vaccine development. Expand
COVID-19 vaccines: where we stand and challenges ahead
It remains to be elucidated whether and to what extent the capacity of vaccines under evaluation and of unrelated vaccines such as BCG can increase immunological fitness by training innate immunity to SARS-CoV-2 and pathogen-agnostic protection. Expand
Viral Vectors for COVID-19 Vaccine Development
Vaccine development against SARS-CoV-2 has been fierce due to the devastating COVID-19 pandemic and has included all potential approaches for providing the global community with safe and efficientExpand
Who is running faster, the virus or the vaccine?
Issues and potential solutions that will require a world collaboration of public authorities, industries and scientists from both physical and social sciences are detailed. Expand
COVID-19: Insights into Potential Vaccines
This review aims to discuss the different vaccine platforms and the clinical trials of the candidate vaccines developed with the release of the genetic sequence of the SARS-CoV-2 virus in January. Expand
Current State of the First COVID-19 Vaccines
This review summarizes the underlying design strategies and current status of development of the nine vaccines that were in phase III trial on 8 November 2020 and details current distribution plans and remaining challenges with vaccine accessibility and acceptance. Expand